MEI Pharma, Inc.
Hedge Funds Holdings
Last updated:
MEI Pharma, Inc.‘s stocks are currently a part of 88 hedge funds’ portfolios, which represents 44.01% of the total amount of its stocks outstanding. This makes up a total of 56.40M shares of MEI Pharma, Inc.. Compared to the previous quarter, the number fell by -36.76% or -32.78M shares fewer. As for the holding position changes, 37.5% (33) of current hedge fund investors increased the number of shares held, 23.86% (21) of current holders sold a part of the shares held, and 40.91% (36) closed the holdings completely. 20 hedge funds are new holders of MEI Pharma, Inc. stock in Q1 2022, it is 22.73% of total holders.
Hedge funds holding MEI Pharma (Q2 2017 – Q1 2022)
| Q2 2017 | 44 |
|---|---|
| Q3 2017 | 52 |
| Q4 2017 | 46 |
| Q1 2018 | 42 |
| Q2 2018 | 59 |
| Q3 2018 | 61 |
| Q4 2018 | 57 |
| Q1 2019 | 62 |
| Q2 2019 | 71 |
| Q3 2019 | 70 |
| Q4 2019 | 79 |
| Q1 2020 | 78 |
| Q2 2020 | 102 |
| Q3 2020 | 104 |
| Q4 2020 | 109 |
| Q1 2021 | 106 |
| Q2 2021 | 108 |
| Q3 2021 | 105 |
| Q4 2021 | 105 |
| Q1 2022 | 88 |
Hedge funds changes in MEI Pharma positions (Q2 2017 – Q1 2022)
| Q2 2017 | 10 | 13 | 13 | 7 | 1 |
|---|---|---|---|---|---|
| Q3 2017 | 19 | 12 | 16 | 9 | -4 |
| Q4 2017 | 8 | 11 | 16 | 13 | -2 |
| Q1 2018 | 5 | 8 | 18 | 9 | 2 |
| Q2 2018 | 25 | 14 | 13 | 8 | -1 |
| Q3 2018 | 11 | 21 | 14 | 9 | 6 |
| Q4 2018 | 12 | 21 | 15 | 15 | -6 |
| Q1 2019 | 10 | 19 | 14 | 6 | 13 |
| Q2 2019 | 22 | 23 | 13 | 13 | 0 |
| Q3 2019 | 9 | 17 | 26 | 10 | 8 |
| Q4 2019 | 19 | 29 | 19 | 9 | 3 |
| Q1 2020 | 11 | 32 | 18 | 12 | 5 |
| Q2 2020 | 33 | 41 | 18 | 9 | 1 |
| Q3 2020 | 19 | 30 | 37 | 17 | 1 |
| Q4 2020 | 15 | 49 | 24 | 10 | 11 |
| Q1 2021 | 12 | 34 | 33 | 15 | 12 |
| Q2 2021 | 11 | 40 | 39 | 9 | 9 |
| Q3 2021 | 7 | 27 | 42 | 9 | 20 |
| Q4 2021 | 21 | 32 | 34 | 20 | -2 |
| Q1 2022 | 20 | 33 | 21 | 36 | -22 |
Hedge funds changes in MEI Pharma stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 25,000 | 4,000 |
|---|---|---|
| Q3 2017 | 1,343,000 | 78,000 |
| Q4 2017 | 83,000 | 55,000 |
| Q1 2018 | 461,000 | 2,000 |
| Q2 2018 | 3,639,000 | 218,000 |
| Q3 2018 | 3,426,000 | 144,000 |
| Q4 2018 | 2,238,000 | 257,000 |
| Q1 2019 | 2,669,000 | 766,000 |
| Q2 2019 | 2,098,000 | 2,149,000 |
| Q3 2019 | 1,059,000 | 1,030,000 |
| Q4 2019 | 1,401,000 | 0 |
| Q1 2020 | 96,000 | 18,000 |
| Q2 2020 | 3,534,000 | 238,000 |
| Q3 2020 | 2,665,000 | 333,000 |
| Q4 2020 | 3,099,000 | 272,000 |
| Q1 2021 | 3,919,000 | 64,000 |
| Q2 2021 | 1,004,000 | 114,000 |
| Q3 2021 | 432,000 | 113,000 |
| Q4 2021 | 2,164,000 | 446,000 |
| Q1 2022 | 910,000 | 63,000 |